$1.710
-0.782 (-45.71%)At close
APTO Comparative Benchmarking
In the context of the broader market, APTO competes directly with industry leaders such as COSM and NEUP. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, APTO's gross margin of N/A stands against COSM's 6.12% and NEUP's N/A. Such benchmarking helps identify whether Aptose Biosciences Inc is trading at a premium or discount relative to its financial performance.
Financials
FY2024Q4
0.00
Total Revenue
FY2024Q4
YoY:
-81.97%
-2.19M
Operating Profit
FY2024Q4
YoY:
-86.74%
-1.58M
Net Income after Tax
FY2024Q4
YoY:
-97.07%
-1.34
EPS - Diluted
FY2024Q4
YoY:
-12.90%
-8.06M
Free Cash Flow
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.